Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions
Response to vaccines generally varies according to individual factors of the vaccinated subjects such as demographics and immune status. While there are various reports of factors associated with immunogenicity of mRNA COVID-19 vaccines, little is known about those of adenovirus vector vaccines. We...
Enregistré dans:
Auteurs principaux: | Sang Won Lee, Ji-Yong Moon, Sun-Kyung Lee, Hyun Lee, SeolHwa Moon, Sung Jun Chung, Yoomi Yeo, Tai Sun Park, Dong Won Park, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Sang-Heon Kim |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2d31818c17c94ad3b1957d1dde88335f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
par: Glenn A. Marsh, et autres
Publié: (2021) -
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
par: Sue Ann Costa Clemens, et autres
Publié: (2021) -
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
par: Robert J. Fischer, et autres
Publié: (2021) -
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
par: Michiko Asano, et autres
Publié: (2022) -
Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
par: Rujittika Mungmunpuntipantip, et autres
Publié: (2021)